Abstract
The ever-evolving research in the field of antitubercular agents has led to the identification of several new potential drug classes. Among them, 5-phenyl-furan-2-carboxylic acids have emerged as innovative potential therapeutics, targeting iron acquisition in mycobacterial species. In our efforts to characterize the molecular interactions between these compounds and their protein target (MbtI from M. tuberculosis) by means of co-crystallization experiments, we unexpectedly obtained the structure of 5-(4-nitrophenyl)furan-2-carboxylic acid (1). Herein, we describe the preparation of the compound and its analysis by 1H NMR, 13C NMR, HRMS, and SC-XRD.
Funder
University of Milan, “Linea B”
Subject
Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry
Reference35 articles.
1. World Health Organization (2021). Global Tuberculosis Report 2021.
2. Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discovery;Cazzaniga;Eur. J. Med. Chem.,2021
3. Ejalonibu, M.A., Ogundare, S.A., Elrashedy, A.A., Ejalonibu, M.A., Lawal, M.M., Mhlongo, N.N., and Kumalo, H.M. (2021). Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach. Int. J. Mol. Sci., 22.
4. Analysis of Approaches to Anti-tuberculosis Compounds;Motamen;ACS Omega,2020
5. Antivirulence compounds: A future direction to overcome antibiotic resistance?;Buroni;Future Microbiol.,2020